Eli Lilly, BDR Pharma ink pact for COVID drug Baricitinib Ruchika Sharma23 May 2021 9:00 AM ISTNew Delhi: Drug firm BDR Pharma on Wednesday said it has inked a licensing pact with Eli Lilly and Company for the manufacturing and distribution...
Natco Pharma enters agreement with Eli Lilly for COVID drug Baricitinib Ruchika Sharma18 May 2021 11:51 AM ISTHyderabad: Drugmaker, Natco Pharma Limited, has recently announced the signing of a royalty-free, non-exclusive, voluntary licensing agreement with...
Torrent Pharma, Eli Lilly ink pact to boost Baricitinib production in India Ruchika Sharma14 May 2021 3:23 PM ISTAhmedabad: Following in the footsteps of Sun Pharma, Cipla, and Lupin in signing a voluntary licencing agreement with Eli Lilly to accelerate the...
Dr Reddys, Eli Lilly collaborate for manufacturing, commercializing Baricitinib in India Ruchika Sharma13 May 2021 9:15 AM ISTHyderabad: Drug major, Dr. Reddy's Laboratories Ltd., has recently announced that the company has entered into a royalty-free, non-exclusive...
Eli Lilly ink licensing pact with Sun Pharma, Cipla, Lupin to expedite COVID drug Baricitinib Ruchika Sharma10 May 2021 1:55 PM ISTNew Delhi: Drug firm Eli Lilly and Company on Monday said it has inked voluntary licensing agreements with Indian drug firms -- Sun Pharma, Cipla...
Natco Pharma launches Baricitinib in India without patent waiver approval Medical Dialogues Team7 May 2021 3:26 PM ISTNew Delhi: Casting caution to the wind, Natco Pharma has already started distributing its generic version of the rheumatoid arthritis drug Baricitinib...
Combating COVID: Eli Lilly accelerating baricitinib availability in India Ruchika Sharma6 May 2021 12:00 PM ISTIndianapolis: Eli Lilly and Company has recently announced new initiatives to help COVID-19 patients in India as part of its commitment to...
Eli Lilly, Asahi Kasei Pharma ink license agreement for chronic pain drug candidate Ruchika Sharma31 Jan 2021 9:30 AM ISTIndianapolis and Tokyo:Eli Lilly and Company and Asahi Kasei Pharma Corporation have recently announced a license agreement whereby Lilly...
Eli Lilly gets CDSCO Committee nod for marketing authorization for Insulin Lispro MD Bureau1 Jan 2021 6:17 PM ISTNew Delhi: In a major rejoice to Eli Lilly and Company (India) Pvt. Ltd., the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Eli Lilly to Acquire Prevail Therapeutics in USD 1.04 Billion deal Ruchika Sharma16 Dec 2020 2:54 PM ISTIndianapolis, New York: Eli Lilly and Company and Prevail Therapeutics Inc. have announced a definitive agreement for Lilly to acquire...
Eli Lilly to supply 650,000 additional Covid doses to US Govt Ruchika Sharma4 Dec 2020 10:00 AM ISTNew Delhi: Eli Lilly and Co said on Wednesday the U.S. government has purchased 650,000 additional doses of its Covid-19 antibody drug for $812.5...
Eli Lilly arthritis drug baricitinib in combination with remdesivir gets USFDA okay to treat Covid Ruchika Sharma22 Nov 2020 11:00 AM ISTNew Delhi: The U.S. Food and Drug Administration on Thursday approved the emergency use of Eli Lilly and Co's arthritis drug, baricitinib, in...
